This company has been marked as potentially delisted and may not be actively trading. DiaMedica Therapeutics (DMA) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock DMA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period DiaMedica targets preeclampsia Phase 2 dose selection and ReMEDy2 interim analysis in H1 2026 as enrollment momentum buildsMay 14, 2025 | msn.comDiaMedica Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DMAC | BenzingaApril 16, 2025 | benzinga.comDiaMedica Therapeutics: Stroke Developer With Low Cash ReserveApril 15, 2025 | seekingalpha.comDiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call TranscriptMarch 18, 2025 | seekingalpha.comCraig-Hallum Remains a Buy on Diamedica Therapeutics (DMAC)February 25, 2025 | markets.businessinsider.comDiaMedica Therapeutics Appoints Daniel J. O’Connor to BoardFebruary 24, 2025 | msn.comDiaMedica Therapeutics: Interesting Work In Treating Ischemic StrokeJanuary 30, 2025 | seekingalpha.comLake Street Reaffirms Their Buy Rating on Diamedica Therapeutics (DMAC)November 16, 2024 | markets.businessinsider.comDiaMedica Therapeutics Reports Q3 2024 Financial ResultsNovember 16, 2024 | markets.businessinsider.comDiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q3 2024 Earnings Call TranscriptNovember 16, 2024 | msn.comDiamedica Therapeutics (DMAC) Receives a Buy from Craig-HallumNovember 12, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Simulations Plus (SLP), Diamedica Therapeutics (DMAC)October 9, 2024 | markets.businessinsider.comDiaMedica Therapeutics Inc. (DMAC) Q2 2024 Earnings Call TranscriptAugust 11, 2024 | seekingalpha.comDiaMedica Therapeutics Inc DMACFebruary 16, 2024 | morningstar.comDiaMedica Therapeutics Inc. (DMAC) Q4 2022 Earnings Call TranscriptMarch 31, 2023 | seekingalpha.comCerevel Therapeutics Holdings (CERE) Shares Cross Below 200 DMAFebruary 24, 2023 | nasdaq.comDiaMedica stock slides 17% after hours as FDA maintains clinical hold on DM199 trialOctober 26, 2022 | seekingalpha.comMEXC Activated the "Investor Protection Fund" in Response to the Dragoma (DMA) Incident, and Launched the "Potion" Airdrop Compensation BenefitsAugust 12, 2022 | finance.yahoo.comDiaMedica Therapeutics Announces Clinical Hold of DM199 Trial, Shares Fall 31%July 8, 2022 | marketwatch.comDiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q1 2022 Results - Earnings Call TranscriptMay 7, 2022 | seekingalpha.com Get DiaMedica Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DMA and its competitors with MarketBeat's FREE daily newsletter. Email Address DMA Media Mentions By Week DMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DMA News Sentiment▼0.000.65▲Average Medical News Sentiment DMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DMA Articles This Week▼00▲DMA Articles Average Week Get DiaMedica Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for DMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Theratechnologies News Oncolytics Biotech News Medicenna Therapeutics News Covalon Technologies News Sernova News Aptose Biosciences News Helix BioPharma News Microbix Biosystems News Devonian Health Group News Hemostemix News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:DMA) was last updated on 6/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredThe IRS Loophole That Lets You Own Gold Tax-FreeWhat if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...Advantage Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DMA Stock Free DMA Stock Alerts